Texas hospitals reported $329 million in estimated costs for care of undocumented patients from Dec 2024 to Feb 2025, highlighting gaps in payment data and uninsured care context.

S&P Global Ratings warns that proposed Medicaid funding cuts and reimbursement freezes may impact U.S. healthcare providers' financial stability, potentially reducing care access and increasing costs.

Research shows that Medicaid cuts risk severing crucial patient-primary care connections, leading to worse health outcomes and higher costs. Stable insurance ensures preventive care and lowers emergency visits and spending.

Pennsylvania Senate passes Bill 95 with amendment requiring pharmacies to disclose retail and generic drug prices upon consumer request, promoting prescription drug cost transparency and informed purchasing decisions.

Explore the Medicare Part D coverage gap's impact on U.S. retirees, with insights on managing prescription drug costs and navigating supplemental insurance options.

Hospices confront rising operational costs, increased audits, and potential Medicare Advantage coverage changes in 2025, impacting hospice care delivery and financial sustainability.

UnitedHealthcare stops paying commissions on Medicare prescription drug plans sold after June 1, 2025, impacting agents amid rising Medicare Advantage costs and prompting calls for CMS intervention.

Analysis reveals Medicaid funding cuts could worsen health outcomes and increase healthcare costs for low-income and older adults, impacting federal and state budgets.

UnitedHealth Group appoints Stephen J. Hemsley as CEO and suspends its 2025 financial outlook due to rising Medicare Advantage medical costs, with growth expected to resume in 2026.

In 2025, major U.S. health insurers face financial and operational setbacks while smaller, focused payers achieve significant growth by leveraging market-specific strategies and managing costs effectively, reshaping the Medicare Advantage and ACA markets.